In Figure 2A, the GSTM2 expression was significantly decreased in colon cancer tissues of patients at stages 1, 2, 3, and 4 versus normal controls, while there was no significant difference between different stages. The gene discussed is GSTM2; the disease is malignant colon neoplasm.